Information Journal Paper
APA:
Copy. (2018). Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. ONCOTARGET, 9(30), 0-0. SID. https://sid.ir/paper/733012/en
Vancouver:
Copy. Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. ONCOTARGET[Internet]. 2018;9(30):0-0. Available from: https://sid.ir/paper/733012/en
IEEE:
Copy, “Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model,” ONCOTARGET, vol. 9, no. 30, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/733012/en